Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 30;114(26):447-454.
doi: 10.3238/arztebl.2017.0447.

The Diagnosis and Treatment of Behavioral Disorders in Dementia

Review

The Diagnosis and Treatment of Behavioral Disorders in Dementia

Torsten Kratz. Dtsch Arztebl Int. .

Abstract

Background: Behavioral disorders such as aggressiveness, agitation, delusions, disinhibition, affect lability, and apathy arise in more than 90% of patients with dementia. Behavioral disorders are a major challenge and the greatest stress factor in everyday life for nursing personnel and for family members caring for the patient.

Methods: This review is based on relevant publications retrieved by a selective literature search in the PubMed, Cochrane Library, and German S3 guideline databases with the search terms "behavioral disorders," "non-cognitive disorders," and "challenging behavior," in conjunction with "dementia" and "behavioral and psychological symptoms of dementia."

Results: Behavioral disorders regularly accompany dementing illness and have identifiable and treatable somatic and environment-related causes. They should be treated symptomatically, both with non-pharmacological measures and with drugs. Memory therapy (d = 0.47), ergotherapy (d = 0.72), music therapy (d = 0.62), and physical exercise (d = 0.68) are effective, as are antidementia drugs (galantamine: p = 0.04, donepezil: p = 0.01, rivastigmine: p = 0.02, memantine: p = 0.004). Risperidone is the drug of choice to combat agitation and aggressiveness (d = 0.33) as well as dementia and hallucinations (d = 0.5). Citalopram can be recommended for the treatment of depression in patients with dementia (p = 0.05).

Conclusion: Because of an improved evidence base, the latest version of the German S3 guideline on the diagnosis and treatment of dementia places greater emphasis on non-pharmacological treatments for behavioral disorders in dementia than it did in the past. The global efficacy of such treatments against behavioral disorders is well documented. Nonetheless, because of the heterogeneity of interventions and varying standards of assessment, the evidence for the utility of certain specific methods in the treatment of specific behavioral disorders is still limited. More research is needed in this area.

PubMed Disclaimer

Comment in

  • Additional Comments.
    J Stein W. J Stein W. Dtsch Arztebl Int. 2017 Nov 3;114(44):753. doi: 10.3238/arztebl.2017.0753a. Dtsch Arztebl Int. 2017. PMID: 29169434 Free PMC article. No abstract available.
  • Paying Attention to Electrolytes.
    Bienentreu S. Bienentreu S. Dtsch Arztebl Int. 2017 Nov 3;114(44):753. doi: 10.3238/arztebl.2017.0753b. Dtsch Arztebl Int. 2017. PMID: 29169435 Free PMC article. No abstract available.

References

    1. Hessler JB, Schäufele M, Hendlmeier I, et al. Behavioural and psychological symptoms in general hospital patients with dementia, distress for nursing staff and complications in care: results of the General Hospital Study. Epidemiol Psychiatr Sci. 2017;9:1–10. - PMC - PubMed
    1. Deuschl G, Maier W. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Neurologie (DGN): Diagnose- und Behandlungsleitlinie Demenz - Interdisziplinäre S3 Praxisleitlinien 2016. www.dgn.org/images/red_leitlinien/LL_2016/PDFs_Download/038013_LL_Demenz... (last accessed on 24 February 2017)
    1. Ballard CG, Gauthier S, Cummings JL, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5:245–255. - PubMed
    1. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. J Neural Transm. 2002;109:341–360. - PubMed
    1. de Vugt ME, Stevens F, Aalten P, Lousberg R, Jaspers N, Verhey FR. A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr. 2005;17:577–589. - PubMed

MeSH terms